EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Personalized Dose of Adjuvant Imatinib in Patients with Gastrointestinal Stromal Tumors: Results from a Population Pharmacokinetic Analysis

Xuehui Jiang iD, Qun Fu, Yan Jing, Ying Kong, Hong Liu, Hongwei Peng, Kaisaner Rexiti, Xiaohua Wei

Drug Design, Development and Therapy · 2023

DOI: 10.2147/dddt.s400986 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Design, Development and Therapy, 2023. Verfasst von Xuehui Jiang und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Nanchang University, Nanchang, People's Republic of China. Hauptthemen laut MEDLINE: Antineoplastic Agents, Gastrointestinal Stromal Tumors, ATP Binding Cassette Transporter, Subfamily G, Member 2. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antineoplastic AgentsGastrointestinal Stromal TumorsATP Binding Cassette Transporter, Subfamily G, Member 2HumansAdjuvants, ImmunologicGenotypeImatinib MesylateNeoplasm Proteins

Stichwörter der Autor:innen

GISTPPKRBCimatinibpersonalized dosepostoperativers2231142

Substanzen

Adjuvants, ImmunologicAntineoplastic AgentsImatinib MesylateATP Binding Cassette Transporter, Subfamily G, Member 2ABCG2 protein, humanNeoplasm Proteins

Autor:innen und Institutionen

  • School of Pharmacy, Nanchang University, Nanchang, People's Republic of China.
  • Department of Pharmacy, The First Affiliated Hospital of Nanchang University, Nanchang, People's Republic of China.
  • Jiangxi Provincial Drug Inspector Center, Jiangxi Provincial Drug Administration, Nanchang, People's Republic of China.
  • Department of Pharmacy, Linyi Central Hospital, Linyi, People's Republic of China.

ORCID-Profile: Xuehui Jiang

Zitieren

APA

Jiang, X., Fu, Q., Jing, Y., Kong, Y., Liu, H., Peng, H., Rexiti, K., & Wei, X. (2023). Personalized Dose of Adjuvant Imatinib in Patients with Gastrointestinal Stromal Tumors: Results from a Population Pharmacokinetic Analysis. Drug Design, Development and Therapy. https://doi.org/10.2147/dddt.s400986

Vancouver

Jiang X, Fu Q, Jing Y, Kong Y, Liu H, Peng H, et al. Personalized Dose of Adjuvant Imatinib in Patients with Gastrointestinal Stromal Tumors: Results from a Population Pharmacokinetic Analysis. Drug Design, Development and Therapy. 2023. doi:10.2147/dddt.s400986

BibTeX
@article{Jiang2023,
  author = {Jiang, Xuehui and Fu, Qun and Jing, Yan and Kong, Ying and Liu, Hong and Peng, Hongwei and Rexiti, Kaisaner and Wei, Xiaohua},
  title = {Personalized Dose of Adjuvant Imatinib in Patients with Gastrointestinal Stromal Tumors: Results from a Population Pharmacokinetic Analysis},
  journal = {Drug Design, Development and Therapy},
  year = {2023},
  doi = {10.2147/dddt.s400986}
}
Kostenlos starten →